The Medicaid Pharmacy and Therapeutics (P&T) Committee was established by state law in 2003 to review and recommend to Medicaid classes of drugs to be included in a mandatory Preferred Drug List. The P&T Committee develops its preferred drug list recommendations by considering the clinical efficacy, safety and cost effectiveness of a product.
The November 9, 2022 P&T Meeting is cancelled due to lack of quorum.